What is MLLNF stock price today?

MLLNF (Malin Corporation plc) stock is trading at $6.40 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MLLNF stock going up or down today?

MLLNF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MLLNF stock now?

The decision to buy MLLNF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MLLNF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MLLNF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MLLNF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MLLNF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MLLNF's P/E ratio?

P/E ratio data for MLLNF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MLLNF's market cap?

MLLNF (Malin Corporation plc) has a market capitalization of $0.03 billion, making it a small-cap stock.

What is MLLNF's price to book ratio?

MLLNF trades at a price-to-book (P/B) ratio of 0.98, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does MLLNF pay dividends?

MLLNF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MLLNF's dividend yield?

MLLNF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MLLNF stock a good long-term investment?

MLLNF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MLLNF's revenue growth rate?

MLLNF has shown revenue growth of 0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for MLLNF are available on our dashboard with complete income statement analysis.

What are the risks of investing in MLLNF?

Key risks for MLLNF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MLLNF compare to its competitors?

Compare MLLNF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MLLNF's performance and positioning.

What is MLLNF's stock price target for 2026?

Our AI model provides price targets for MLLNF based on fundamental analysis: Bull case $8.32 (+30%), Base case $7.36 (+15%), Bear case $5.76 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MLLNF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MLLNF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MLLNF's next earnings report?

MLLNF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MLLNF - Malin Corporation plc

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$6.40

+$0.00 (+0.00%)

About Malin Corporation plc

Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.

MLLNF Key Statistics

Market Cap

$27.69M

P/B Ratio

0.98

EPS

$-0.04

Revenue Growth

+0.2%

Employees

How MLLNF Compares to Peers

MLLNF ranks 2nd in revenue growth vs peers

MLLNF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MLLNF(This stock)	$27.69M	N/A	0%	0.0%	-
LLYEli Lilly	$824.74B	40.2	0%	0.3%	vs LLY
JNJJohnson &	$544.88B	20.5	0%	0.2%	vs JNJ
PFEPfizer Inc	$152.45B	19.7	-0%	0.1%	vs PFE
MRKMerck &	$279.11B	15.5	0%	0.3%	vs MRK
ABBVAbbvie Inc	$354.64B	84.6	0%	0.1%	vs ABBV

Malin Corporation plc Company Information

Headquarters: The Lennox Building, Dublin, Ireland, D02 FK02, undefined
Website: malinplc.com
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Data Updated: April 24, 2026 at 2:14 PM EDT

Ready to invest in MLLNF?

Commission-free trading available. Affiliate links.

Upcoming Events for MLLNF

Dashboard

Enter a ticker to analyze